Atlas Trials

An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris

Clinical trial NCT02682264 · COMPLETED

Trial details

NCT number
NCT02682264
Sponsor
Cassiopea SpA
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2016-03-09
Primary completion
2018-08-31
Enrollment
609

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.